Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia

American Journal of Psychiatry

Volumn 154, Issue 8, 1997, Pages 1063-1069

  Pietrini, Pietro ^a   Dani, Alessio ^a   Furey, Maura L ^a   Alexander, Gene E ^a   Freo, Ulderico ^a   Grady, Cheryl L ^a   Mentis, Marc J ^a   Mangot, David ^a   Simon, Elliott W ^a   Horwitz, Barry ^a   Haxby, James V ^a   Schapiro, Mark B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN DEPTH STIMULATION; DEMENTIA; DOWN SYNDROME; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NEUROPATHOLOGY; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 21;

EID: 0030753975     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.8.1063     Document Type: Article

References (31)

1. Burger PC, Vogel FS: The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 1973; 73:457-476
2. Wisniewki KE, Wisniewki HM, Wen GY: Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985; 17:278-282
3. Haxby JV, Schapiro MB: Longitudinal study of neuropsychological function in older adults with Down syndrome, in Down Syndrome and Alzheimer Disease. Edited by Epstein C, Nadel L. New York, Wiley-Liss, 1992, pp 35-50
4. Lai F, Williams RS: A prospective study of Alzheimer's disease in Down syndrome. Arch Neurol 1989; 46:849-853
5. Schapiro MB, Grady CL, Haxby JV: Nature of mental retardation and dementia in Down's syndrome: study with PET, CT, and neuropsychology. Neurobiol Aging 1992; 13:723-734
6. Holland AJ, Oliver C: Down's syndrome and the links with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995; 39:111-114
7. Dani A, Pietrini P, Furey M, McIntosh AR, Grady CL, Horwitz B, Freo U, Alexander GE, Schapiro MB: Brain cognition and metabolism in Down syndrome adults in association with development of dementia. Neuroreport 1996; 7:2933-2936
8. Schapiro MB, Grady CL, Kumar A, Herscovitch P, Haxby JV, Moore AM, White B, Friedland RP, Rapoport SI: Regional cerebral glucose metabolism is normal in young adults with Down syndrome. J Cereb Blood Flow Metab 1989; 10:199-206
9. Haxby JV, Duara R, Grady CL, Cutler NR, Rapoport SI: Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J Cereb Blood Flow Metab 1985; 5:193-200
10. Hatanpää K, Brady DR, Stoll J, Chandrasekaran K: Neuronal activity and early neurofibrillary tangles in Alzheimer disease. Ann Neurol 1996; 40:411-420
11. Terman LM, Merrill MA: Stanford-Binet Intelligence Scale: Manual for the Third Revision, Form L-M. Boston, Houghton-Mifflin, 1973
12. Dunn LM, Dunn LM: Peabody Picture Vocabulary Test - Revised. Circle Pines, NMex, American Guidance Service, 1981
13. Haxby JV: Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. J Ment Defic Res 1989; 33(part 3):193-210
14. Schapiro MB, Haxby JV, Grady CL, Duara R, Schlageter NL, White B, Moore A, Sundaram M, Larson SM, Rapoport SI: Decline in cerebral glucose utilization and cognitive function with aging in Down's syndrome. J Neurol Neurosurg Psychiatry 1987; 50:766-774
15. Schapiro MB, Luxenberg JS, Kaye JA, Haxby JV, Friedland RP, Rapoport SI: Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Neurology 1989; 39:1349-1353
16. Brooks RA: Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 1982; 23:538-539
17. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurado O, Shinohara M: The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28:897-916
18. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE: Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980; 238:E69-E82
19. Kumar A, Schapiro MB, Grady CL, Haxby JV, Wagner E, Salerno J, Rapoport SI: High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991; 4:35-46
20. Eycleshymer AC, Shoemaker DM: A Cross-Section Anatomy. New York, Appleton, 1911
21. Brooks RA, Di Chiro G, Zukerberg BW, Bairamian D, Larson S: Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. J Nucl Med 1987; 28: 53-59
22. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI: Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46:518-523
23. Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB: Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am J Psychiatry 1996; 153: 1261-1268
24. Frackowiak RS, Pozzilli C, Legg NJ, DuBoulay GH, Marshall J, Lenzi GL, Jones T: Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron tomography. Brain 1981; 104(part4):753-778
25. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, Friedland RP, Rapoport SI: Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988; 10:576-596
26. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro MB, Friedland RP, Rapoport SI: Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990; 47:753-760
27. Pietrini P, Azari NP, Grady CL, Salerno JA, Gonzales-Aviles A, Heston L, Pettigrew KD, Horwitz B, Schapiro MB: Pattern of cerebral metabolic interactions in a subject at risk for Alzheimer's disease. Dementia 1993; 4:94-101
28. Pietrini P, Dani A, Freo U, Horwitz B, Grady CL, Maisog J, Guazzelli M, Rapoport SI, Schapiro MB: Positron emission tomography study of regional cerebral blood flow and glucose metabolism at rest and during activation in healthy human aging, in Abstract Book of the Sixth Congress of the International Psychogeriatrics Association. Skokie, Ill, IPA, 1993, p 25
29. Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Mandel F, Alexander GE, Grady CL, Pietrini P, Eidelberg D: The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996; 16:385-398
30. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, Guze BH, Corder EH, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD: Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995; 273:942-947
31. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996; 334:752-758